Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination

BACKGROUND: The COVIH study is a prospective coronavirus disease 2019 (COVID-19) vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody levels after primary vaccination. We evaluated whether an additional vaccination boosts immune responses in these hyporesponders. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Jongkees, Marlou J, Geers, Daryl, Hensley, Kathryn S, Huisman, Wesley, GeurtsvanKessel, Corine H, Bogers, Susanne, Gommers, Lennert, Papageorgiou, Grigorios, Jochems, Simon P, den Hollander, Jan G, Schippers, Emile F, Ammerlaan, Heidi S M, Bierman, Wouter F W, van der Valk, Marc, Berrevoets, Marvin A H, Soetekouw, Robert, Langebeek, Nienke, Bruns, Anke H W, Leyten, Eliane M S, Sigaloff, Kim C E, van Vonderen, Marit G A, Delsing, Corine E, Branger, Judith, Katsikis, Peter D, Mueller, Yvonne M, de Vries, Rory D, Rijnders, Bart J A, Brinkman, Kees, Rokx, Casper, Roukens, Anna H E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978319/
https://www.ncbi.nlm.nih.gov/pubmed/36402141
http://dx.doi.org/10.1093/infdis/jiac451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978319/
https://www.ncbi.nlm.nih.gov/pubmed/36402141
http://dx.doi.org/10.1093/infdis/jiac451

Ejemplares similares